Cargando…
Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll‐Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells
LL‐37 is a cationic antimicrobial peptide and the sole human member of cathelicidins. Besides its bactericidal properties, LL‐37 is known to have direct immunomodulatory effects, among which enhancement of antiviral responses via endosomal toll‐like receptors (TLRs). Omiganan pentahydrochloride is a...
Autores principales: | Grievink, Hendrika W., Jirka, Silvana M. G., Woutman, Tess D., Schoonakker, Mascha, Rissmann, Robert, Malone, Karen E., Feiss, Gary, Moerland, Matthijs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485948/ https://www.ncbi.nlm.nih.gov/pubmed/32314872 http://dx.doi.org/10.1111/cts.12789 |
Ejemplares similares
-
Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers
por: Niemeyer‐van der Kolk, Tessa, et al.
Publicado: (2020) -
Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy Volunteers
por: Buters, Thomas P., et al.
Publicado: (2022) -
Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study
por: in ‘t Veld, Aliede E., et al.
Publicado: (2023) -
Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial
por: Niemeyer‐van der Kolk, Tessa, et al.
Publicado: (2020) -
Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers
por: Buters, Thomas P., et al.
Publicado: (2021)